Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. April 2026 12:19 ET | Quelle: Research and Markets

Contract Research and Manufacturing Services (CRAMS) Research Report 2026: $258.36 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Contract Research and Manufacturing Services (CRAMS) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Contract...
30. April 2026 07:05 ET | Quelle: AC Immune SA

AC Immune First Quarter 2026 Financial and Corporate Updates

AC Immune First Quarter 2026 Financial and Corporate Updates Dosed first subjects in Phase 1 trial of brain-penetrant small molecule NLRP3 inhibitor ACI-19764 with SAD/MAD results in healthy...
30. April 2026 07:00 ET | Quelle: AC Immune SA

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease Treatment of first patient in Cohort AD4 in ABATE trial triggers $12...
27. April 2026 16:05 ET | Quelle: Structure Therapeutics Inc.

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
20. April 2026 05:58 ET | Quelle: Research and Markets

Biologics Contract Research Organization Market Industry Trends and Forecasts 2026-2035: Big Pharma Outsources 45% of R&D as 160 Specialized CROs Reshape the Biopharmaceutical Research Landscape

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation,...
16. April 2026 10:44 ET | Quelle: Research and Markets

Global Pharmaceutical Industry Opportunity Outlook Report 2026: GLP-1 Therapies and ADCs are Key Innovation Drivers, Particularly in Cardiometabolic and Oncology Segments

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Pharmaceutical Industry, 2026" report has been added to ResearchAndMarkets.com's offering.The global pharmaceutical...
13. April 2026 05:56 ET | Quelle: Research and Markets

COVID 19 Market Research and Competitive Landscape Report 2026

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "COVID 19 - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a detailed examination of over...
13. April 2026 05:47 ET | Quelle: Research and Markets

Bispecific Antibodies Market Research and Competitive Landscape Report 2026: Comprehensive Insights Into Over 180 Companies and 250 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive...
13. April 2026 05:28 ET | Quelle: Research and Markets

RNA Therapies Market Research and Competitive Landscape Report 2026

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "RNA Therapies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides detailed insights into 80+...
09. April 2026 04:44 ET | Quelle: Research and Markets

Biopharmaceutical CMO & CRO (Analytical, Cell Culture, Clinical Development, Fill-Finish, Formulation, Preclinical Development, Process Development) Market Research & Global Forecast Report 2026-2032

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...

Nächste Seite